| Application no. and date | 18815624.4 (espacenet) (Federated) (European Patent Register), 20181204 | | Patent/reg. no. and date | DK/EP 3720433, 20220202 | | Publication date | 20201014 | | Priority no. and date | US 201762594184 P, 20171204, US 201862646553 P, 20180322, US 201862655568 P, 20180410, US 201862669095 P, 20180509, US 201862741313 P, 20181004, US 201862750595 P, 20181025 | | EP pub. no. and date |
EP 3720433 20201014 | | Effective date | | | Applicant/owner | Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard
Boston, MA 02210, US | | Applicant ref. no. | 1631319 | | Inventor | ALA, Aftab, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
BJARTMAR, Carl, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
WEISS, Karl-Heinz, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
SCHILSKY, Michael, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
ASKARI, Frederick, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
CZLONKOWSKA, Anna, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
FERENCI, Peter, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE,
HEDERA, Peter, c/o Wilson Therapeutics AB
Kungsgatan 3
111 43 Stockholm, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 31/28 (2006.01) , A61P 3/00 (2006.01) | | Title | BIS-CHOLIN-TETRATHIOMOLYBDAT TIL BEHANDLING AF WILSONS SYGDOM | | Int. application no. | EP2018083551 | | Int. publication no. | WO2019110619 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
